Replies to post #110977 on Cytodyn Inc (CYDY)

[B52T38]

You make a great point, moneycrew! I don't have a long history with CYDY, but isn't it unusual to release a PR at this time of night?

Maybe the PR people (person) are just so busy that they issued the news without any strategy/plan re: max benefit to the company.

Or maybe there is something else coming tomorrow AM.

Or maybe this is just to throw off some of the shorting pressure, i.e., set a pattern of releasing positive PR's at any time?

Regardless, the next 8 weeks should not lack for shock and awe, let's (re)light this candle!

[justdafactss]

Seems NP panicked and needed a diversion PR to draw attention away from this DD:

Says here CYDY never applied for Emergency Use Authorization (EUA)-

Late-stage biotech CytoDyn Inc (CYDY) has announced that it has provided its Top-line Report from its recently completed Phase 2 trial of leronlimab for COVID-19 patients with mild-to-moderate symptoms to the U.S. Food and Drug Administration (FDA), and requested emergency use approval.
https://finance.yahoo.com/news/cytodyn-requests-covid-19-emergency-125739300.html

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157875581